Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

p21-activated kinase improves cardiac contractility during ischemia-reperfusion concomitant with changes in troponin-T and myosin light chain 2 phosphorylation.

Monasky MM, Taglieri DM, Patel BG, Chernoff J, Wolska BM, Ke Y, Solaro RJ.

Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H224-30. doi: 10.1152/ajpheart.00612.2011. Epub 2011 Oct 28.

2.

Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signalling.

Davis RT 3rd, Simon JN, Utter M, Mungai P, Alvarez MG, Chowdhury SA, Heydemann A, Ke Y, Wolska BM, Solaro RJ.

Cardiovasc Res. 2015 Dec 1;108(3):335-47. doi: 10.1093/cvr/cvv234. Epub 2015 Oct 12.

3.

Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.

Zhong B, Wang DH.

Am J Physiol Regul Integr Comp Physiol. 2009 Dec;297(6):R1681-90. doi: 10.1152/ajpregu.90746.2008. Epub 2009 Oct 7.

4.

Degradation of cardiac myosin light chain kinase by matrix metalloproteinase-2 contributes to myocardial contractile dysfunction during ischemia/reperfusion.

Gao L, Zheng YJ, Gu SS, Tan JL, Paul C, Wang YG, Yang HT.

J Mol Cell Cardiol. 2014 Dec;77:102-12. doi: 10.1016/j.yjmcc.2014.10.004. Epub 2014 Oct 18.

PMID:
25451385
5.

Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning.

Morrison RR, Tan XL, Ledent C, Mustafa SJ, Hofmann PA.

Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2523-9. Epub 2007 Aug 3.

6.

Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.

Sánchez JA, Rodríguez-Sinovas A, Barba I, Miró-Casas E, Fernández-Sanz C, Ruiz-Meana M, Alburquerque-Béjar JJ, García-Dorado D.

Basic Res Cardiol. 2013 May;108(3):351. doi: 10.1007/s00395-013-0351-3. Epub 2013 Apr 18.

PMID:
23595215
7.

Myocardial injury after ischemia-reperfusion in mice deficient in Akt2 is associated with increased cardiac macrophage density.

Li X, Mikhalkova D, Gao E, Zhang J, Myers V, Zincarelli C, Lei Y, Song J, Koch WJ, Peppel K, Cheung JY, Feldman AM, Chan TO.

Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H1932-40. doi: 10.1152/ajpheart.00755.2010. Epub 2011 Sep 2.

8.

Diacylglycerol kinase α exacerbates cardiac injury after ischemia/reperfusion.

Sasaki T, Shishido T, Kadowaki S, Kitahara T, Suzuki S, Katoh S, Funayama A, Netsu S, Watanabe T, Goto K, Takeishi Y, Kubota I.

Heart Vessels. 2014 Jan;29(1):110-8. doi: 10.1007/s00380-013-0366-6. Epub 2013 May 30.

PMID:
23719772
9.

Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes.

Sheehan KA, Ke Y, Wolska BM, Solaro RJ.

Am J Physiol Cell Physiol. 2009 Jan;296(1):C47-58. doi: 10.1152/ajpcell.00012.2008. Epub 2008 Oct 15.

10.

Cardiomyocyte-specific overexpression of an active form of Rac predisposes the heart to increased myocardial stunning and ischemia-reperfusion injury.

Talukder MA, Elnakish MT, Yang F, Nishijima Y, Alhaj MA, Velayutham M, Hassanain HH, Zweier JL.

Am J Physiol Heart Circ Physiol. 2013 Jan 15;304(2):H294-302. doi: 10.1152/ajpheart.00367.2012. Epub 2012 Nov 16.

11.

Post-translational modifications of myofilament proteins involved in length-dependent prolongation of relaxation in rabbit right ventricular myocardium.

Monasky MM, Taglieri DM, Jacobson AK, Haizlip KM, Solaro RJ, Janssen PM.

Arch Biochem Biophys. 2013 Jul 1;535(1):22-9. doi: 10.1016/j.abb.2012.10.005. Epub 2012 Oct 19.

12.

Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.

Morrison A, Yan X, Tong C, Li J.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H895-902. doi: 10.1152/ajpheart.00137.2011. Epub 2011 Jun 10.

13.

Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.

Abdillahi M, Ananthakrishnan R, Vedantham S, Shang L, Zhu Z, Rosario R, Zirpoli H, Bohren KM, Gabbay KH, Ramasamy R.

Am J Physiol Heart Circ Physiol. 2012 Aug 1;303(3):H297-308. doi: 10.1152/ajpheart.00999.2011. Epub 2012 Jun 1.

14.

Myocardial reperfusion injury management: erythropoietin compared with postconditioning.

Tamareille S, Ghaboura N, Treguer F, Khachman D, Croué A, Henrion D, Furber A, Prunier F.

Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2035-43. doi: 10.1152/ajpheart.00472.2009. Epub 2009 Jul 17. Erratum in: Am J Physiol Heart Circ Physiol. 2009 Dec;297:H2035.

15.

Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia.

Wang M, Wang Y, Weil B, Abarbanell A, Herrmann J, Tan J, Kelly M, Meldrum DR.

Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R972-8. doi: 10.1152/ajpregu.00045.2009. Epub 2009 Feb 11.

16.

Ischemic preconditioning fails to confer additional protection against ischemia-reperfusion injury in the hypothyroid rat heart.

Mourouzis I, Dimopoulos A, Saranteas T, Tsinarakis N, Livadarou E, Spanou D, Kokkinos AD, Xinaris C, Pantos C, Cokkinos DV.

Physiol Res. 2009;58(1):29-38. Epub 2008 Jan 17.

17.

Cardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion.

Aoyagi T, Higa JK, Aoyagi H, Yorichika N, Shimada BK, Matsui T.

Am J Physiol Heart Circ Physiol. 2015 Jun 15;308(12):H1530-9. doi: 10.1152/ajpheart.00008.2015. Epub 2015 Apr 17.

18.

A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning.

Vessey DA, Li L, Jin ZQ, Kelley M, Honbo N, Zhang J, Karliner JS.

Oxid Med Cell Longev. 2011;2011:961059. doi: 10.1155/2011/961059. Epub 2011 Apr 18.

19.

Cardiac-Specific Deletion of the Pdha1 Gene Sensitizes Heart to Toxicological Actions of Ischemic Stress.

Sun W, Quan N, Wang L, Yang H, Chu D, Liu Q, Zhao X, Leng J, Li J.

Toxicol Sci. 2016 May;151(1):193-203. doi: 10.1093/toxsci/kfw035. Epub 2016 Feb 15. Erratum in: Toxicol Sci. 2016 Oct;153(2):411.

20.

Is reduced SERCA2a expression detrimental or beneficial to postischemic cardiac function and injury? Evidence from heterozygous SERCA2a knockout mice.

Talukder MA, Kalyanasundaram A, Zuo L, Velayutham M, Nishijima Y, Periasamy M, Zweier JL.

Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1426-34. doi: 10.1152/ajpheart.01016.2007. Epub 2008 Jan 18.

Supplemental Content

Support Center